- Events & ActivityEvents & Activity
- DNA ImmunoBody Patent Granted in Europe
- Holding(s) in Company
- Results of Placing
- Proposed Placing to Raise up to Â£5.0 million
- Change of Registered Office
- Immuno-Oncology Summit Europe 2017
- Hardman Research: SCIB development update
- Interim Results
- Partnership to Advance Lung Cancer Clinical Trials
- Research Update - Amendment
Scancell Holdings PLC (SCLP:LSE) closed at 10.38, 7.21% above its 52-week low of 9.68, set on May 11, 2017.
9.68May 11 201719.70Jul 19 2016
|Market cap||31.60m GBP|
|EPS (TTM)||-0.0127 |
Data delayed at least 20 minutes, as of Jun 26 2017 16:20 BST.